188 related articles for article (PubMed ID: 15143187)
1. Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity.
Argetsinger LS; Kouadio JL; Steen H; Stensballe A; Jensen ON; Carter-Su C
Mol Cell Biol; 2004 Jun; 24(11):4955-67. PubMed ID: 15143187
[TBL] [Abstract][Full Text] [Related]
2. Tyrosines 868, 966, and 972 in the kinase domain of JAK2 are autophosphorylated and required for maximal JAK2 kinase activity.
Argetsinger LS; Stuckey JA; Robertson SA; Koleva RI; Cline JM; Marto JA; Myers MG; Carter-Su C
Mol Endocrinol; 2010 May; 24(5):1062-76. PubMed ID: 20304997
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor.
Mazurkiewicz-Munoz AM; Argetsinger LS; Kouadio JL; Stensballe A; Jensen ON; Cline JM; Carter-Su C
Mol Cell Biol; 2006 Jun; 26(11):4052-62. PubMed ID: 16705159
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone.
Yamauchi T; Ueki K; Tobe K; Tamemoto H; Sekine N; Wada M; Honjo M; Takahashi M; Takahashi T; Hirai H; Tushima T; Akanuma Y; Fujita T; Komuro I; Yazaki Y; Kadowaki T
Nature; 1997 Nov; 390(6655):91-6. PubMed ID: 9363897
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta.
Kurzer JH; Argetsinger LS; Zhou YJ; Kouadio JL; O'Shea JJ; Carter-Su C
Mol Cell Biol; 2004 May; 24(10):4557-70. PubMed ID: 15121872
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor.
VanderKuur JA; Wang X; Zhang L; Allevato G; Billestrup N; Carter-Su C
J Biol Chem; 1995 Sep; 270(37):21738-44. PubMed ID: 7545168
[TBL] [Abstract][Full Text] [Related]
7. Regulation of JAK2 protein expression by chronic, pulsatile GH administration in vivo: a possible mechanism for ligand enhancement of signal transduction.
Zhou Y; Wang X; Hadley J; Corey SJ; Vasilatos-Younken R
Gen Comp Endocrinol; 2005 Nov; 144(2):128-39. PubMed ID: 15993410
[TBL] [Abstract][Full Text] [Related]
8. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase.
Argetsinger LS; Campbell GS; Yang X; Witthuhn BA; Silvennoinen O; Ihle JN; Carter-Su C
Cell; 1993 Jul; 74(2):237-44. PubMed ID: 8343952
[TBL] [Abstract][Full Text] [Related]
9. Determination of the transphosphorylation sites of Jak2 kinase.
Matsuda T; Feng J; Witthuhn BA; Sekine Y; Ihle JN
Biochem Biophys Res Commun; 2004 Dec; 325(2):586-94. PubMed ID: 15530433
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
[TBL] [Abstract][Full Text] [Related]
11. Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements.
Huang Y; Kim SO; Yang N; Jiang J; Frank SJ
Mol Endocrinol; 2004 Jun; 18(6):1471-85. PubMed ID: 15044591
[TBL] [Abstract][Full Text] [Related]
12. Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation.
Wang X; Darus CJ; Xu BC; Kopchick JJ
Mol Endocrinol; 1996 Oct; 10(10):1249-60. PubMed ID: 9121492
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of the Janus kinase 2 activation loop is essential for a high-activity catalytic state but dispensable for a basal catalytic state.
Chatti K; Farrar WL; Duhé RJ
Biochemistry; 2004 Apr; 43(14):4272-83. PubMed ID: 15065871
[TBL] [Abstract][Full Text] [Related]
15. Roles of JAK kinase in human GM-CSF receptor signals.
Watanabe S; Itoh T; Arai K
Leukemia; 1997 Apr; 11 Suppl 3():76-8. PubMed ID: 9209304
[TBL] [Abstract][Full Text] [Related]
16. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
17. Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of jak2 tyrosine kinase autophosphorylation [correction of autophophorylation].
Sandberg EM; Ma X; He K; Frank SJ; Ostrov DA; Sayeski PP
J Med Chem; 2005 Apr; 48(7):2526-33. PubMed ID: 15801842
[TBL] [Abstract][Full Text] [Related]
18. Janus kinase 2 (Jak2) must be catalytically active to associate with the AT1 receptor in response to angiotensin II.
Ali MS; Sayeski PP; Safavi A; Lyles M; Bernstein KE
Biochem Biophys Res Commun; 1998 Aug; 249(3):672-7. PubMed ID: 9731195
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of Jak2 in the JH2 domain inhibits cytokine signaling.
Feener EP; Rosario F; Dunn SL; Stancheva Z; Myers MG
Mol Cell Biol; 2004 Jun; 24(11):4968-78. PubMed ID: 15143188
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation.
Xie S; Wang Y; Liu J; Sun T; Wilson MB; Smithgall TE; Arlinghaus RB
Oncogene; 2001 Sep; 20(43):6188-95. PubMed ID: 11593427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
